Skip to content

Medpace Voice

Category: Clinical Development

Clinical Development

How CRO’s Can Help You Navigate New Regulations in Pharmacovigilance

  • July 26, 2018

With significant developments being continually implemented within pharmacovigilance, sponsors and marketing authorisation holders across the globe must ensure they are up-to-date with the frequently changing…

Clinical Development

Patient-Focused Clinical Trial Design for Rare Diseases – Part 2

  • July 11, 2018

In our previous post, we discussed how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate rare disease clinical research. Yet, as…

Clinical Development

Patient-Focused Clinical Trial Design for Rare Diseases – Part 1

  • June 13, 2018

A few months ago, Medpace and the Cincinnati Children’s Hospital Medical Center presented a webinar on the importance of patient-centric clinical research. Over the next…

Clinical Development

Q&A with Dr. Richard Scheyer: Novel Approaches to Confirming CNS Penetration and Target Engagement

  • May 29, 2018

Richard Scheyer, MD, Vice President, Medical Affairs at Medpace answers some questions about his upcoming presentation about CNS-targeted therapies at DIA 2018.

Clinical Development

Q&A from the webinar: Understanding the Hidden Landmines in Medical Device Clinical Research

  • May 7, 2018

Medpace medical device experts—who are directly involved with clinical research—presented a webinar on how to avoid the hidden costs associated with conducting clinical trials. Audience…

Clinical Development

How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3

  • April 18, 2018

In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients…

Clinical Development

Detection of Familial Hypercholesterolemia in South Africa via Cascade Screening

  • March 27, 2018

Experts in Familial hypercholesterolemia (FH) from the Medpace Central Lab were authors on a scientific poster presented at the American College of Cardiology’s 2018 Annual…

Clinical Development

How to Identify, Enroll, and Retain Rare Disease Populations in Clinical Trials

  • February 20, 2018

Enrolling enough subjects into a rare disease study can seem like an insurmountable challenge, especially when you're looking at a subset of a rare disease,…

Clinical Development

The Potential Power of the Human Microbiome for Drug Development

  • February 6, 2018

The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity…

Clinical Development

Key Issues to Consider When Initiating a Clinical Trial

  • January 26, 2018

In a recent article published in the November 2017 edition of the European Biopharmaceutical Review, experts from Medpace discuss key issues that need to be…